Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02199080
Other study ID # 2014/P02/001
Secondary ID 2013-A01700-45
Status Completed
Phase N/A
First received
Last updated
Start date July 28, 2014
Est. completion date May 2016

Study information

Verified date October 2023
Source Groupe Hospitalier de la Rochelle Ré Aunis
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether D-dimer dosage allow to exclude risk of intraatrial thrombus before performing an ablation of atrial fibrillation


Recruitment information / eligibility

Status Completed
Enrollment 2506
Est. completion date May 2016
Est. primary completion date January 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age> 18 years. - Patients hospitalized for ablation of atrial fibrillation or symptomatic left flutter - Patient informed of the study Exclusion Criteria: - Age <18 years. - Patients under guardianship - Pregnant woman - Contraindication to transesophageal echocardiography - transesophageal echocardiography made in another center as the center of ablation - Refusal of the patient to participate in the study - Patient participating in another interventional study in which an intervention related to biomedical research is performed before the transesophageal echocardiography

Study Design


Related Conditions & MeSH terms


Intervention

Other:
D-dimer assay before ablation of atrial fibrillation
Blood sample collection for D-dimers measurement

Locations

Country Name City State
France Service de cardiologie, CH de la Région d'Annecy Annecy
France Centre Hospitalier d' Auxerre Auxerre
France Service de cardiologie, CH Avignon Avignon
France Clinique La Fourcade Bayonne
France Service de cardiologie, CHU Bordeaux Bordeaux
France Service de cardiologie, CHU Brest Brest
France Service de cardiologie, CHU Caen Caen
France Service de cardiologie, CHU Clermont Ferrand Clermont Ferrand
France Service de cardiologie, AP Hôpital Henri Mondor Créteil
France Service de cardiologie, CHU Dijon Dijon
France Groupe Hospitalier de la Rochelle Ré Aunis La Rochelle
France Service de cardiologie, CH Le Mans Le Mans
France Service de cardiologie, CHU Limoges Limoges
France Service de cardiologie, HCL Groupement Est Lyon
France Service de cardiologie, APM Hôpital de La Timone Marseille
France Service de cardiologie, CHI Aix Pertuis CHPA-CHIAP Marseille
France Service de cardiologie, Hôpital Saint Joseph Marseille
France Service de cardiologie, Institut Jacques Cartier Massy
France Service de cardiologie, CHR Metz Thionville Metz
France Service de cardiologie, CHI Le Raincy Montfermeil Montfermeil
France Service de cardiologie, CHU Nancy Nancy
France Service de cardiologie, Nouvelles Cliniques Nantaises Nantes
France Service de cardiologie, CHU Nîmes Nîmes
France Service de cardiologie, HP Les Franciscaines Nîmes
France Service de cardiologie, AP Hôpital la Pitié Salpêtrière Paris
France Service de cardiologie, Groupe Hospitalier Bichat Claude Bernard Paris
France Service de cardiologie, Institut Mutualiste Montsouris Paris
France Service de cardiologie, CH Pau Pau
France Service de cardiologie, CHU Poitiers Poitiers
France Service de cardiologie, CHU Rennes Rennes
France Service de cardiologie, CHU Rouen Rouen
France Service de cardiologie, Centre Cardiologique du Nord Saint Denis
France Service de cardiologie, CHU Saint Etienne Saint Etienne
France Service de cardiologie, CHU Toulouse Hôtel Dieu St Jacques Toulouse
France Service de cardiologie, Clinique Saint Gatien Tours
France Service de cardiologie, Clinique Saint Joseph Trélaze
France Service de cardiologie, Polyclinique Vauban Valenciennes

Sponsors (2)

Lead Sponsor Collaborator
Groupe Hospitalier de la Rochelle Ré Aunis Medtronic

Country where clinical trial is conducted

France, 

References & Publications (1)

Milhem A, Ingrand P, Treguer F, Cesari O, Da Costa A, Pavin D, Rivat P, Badenco N, Abbey S, Zannad N, Winum PF, Mansourati J, Maury P, Bader H, Savoure A, Sacher F, Andronache M, Allix-Beguec C, De Chillou C, Anselme F; ATE Study Group. Exclusion of Intra — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Patients With Atrial Thrombus Diagnosed by Transoesophageal Ultrasound up to 48 hours before ablation
Secondary CHADS2 Score CHADS2 score (congestive heart failure=1, hypertension=1, diabetes mellitus=1, history of stroke or transient ischemic attack=1, and age under 75=1) 48 hours before ablation
Secondary Risk Factors variables related to the presence of atrial thrombus 48 hours before ablation
Secondary Atrial Thrombus Exclusion (ATE) Score The following thromboembolic risk factors mark 1 point if present in patient:
hypertension = 1 point
cardiac insufficiency = 1 point
history of stoke = 1 point
d-dimer level >270ng/mL = 1 point The sum corresponds to the ATE score
48 hours before ablation
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Completed NCT04571385 - A Study Evaluating the Efficacy and Safety of AP30663 for Cardioversion in Participants With Atrial Fibrillation (AF) Phase 2
Terminated NCT04115735 - His Bundle Recording From Subclavian Vein
Completed NCT05366803 - Women's Health Initiative Silent Atrial Fibrillation Recording Study N/A
Completed NCT02864758 - Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France
Recruiting NCT05442203 - Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease N/A
Completed NCT05599308 - Evaluation of Blood Pressure Monitor With AFib Screening Feature N/A
Completed NCT03790917 - Assessment of Adherence to New Oral anTicoagulants in Atrial Fibrillation patiEnts Within the Outpatient registrY
Enrolling by invitation NCT05890274 - Atrial Fibrillation (AF) and Electrocardiogram (EKG) Interpretation Project ECHO N/A
Recruiting NCT05266144 - Atrial Fibrillation Patients Treated With Catheter Ablation
Recruiting NCT05316870 - Construction and Effect Evaluation of Anticoagulation Management Model in Atrial Fibrillation N/A
Not yet recruiting NCT06023784 - The Impact of LBBAP vs RVP on the Incidence of New-onset Atrial Fibrillation in Patients With Atrioventricular Block N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Recruiting NCT04092985 - Smart Watch iECG for the Detection of Cardiac Arrhythmias
Completed NCT04087122 - Evaluate the Efficiency Impact of Conducting Active Temperature Management During Cardiac Cryoablation Procedures N/A
Completed NCT06283654 - Relieving the Emergency Department by Using a 1-lead ECG Device for Atrial Fibrillation Patients After Pulmonary Vein Isolation
Recruiting NCT05416086 - iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)
Completed NCT04546763 - Study Watch AF Detection At Home
Completed NCT03761394 - Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke N/A